|
Market Closed -
Xetra
16:35:27 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 2.818 EUR | -3.82% |
|
+0.28% | -48.29% |
| 10-30 | Evotec SE : RBC gives a Buy rating | ZD |
| 10-30 | RBC cuts target for Evotec to €5 - "Speculative Risk" | DP |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 559M | - | ||||
| 63.77B | |||||
| 56.37B | |||||
| 54.62B | |||||
| 44.06B | |||||
| 42.11B |
- Stock Market
- Stocks
- EVT Stock
- Charts Evotec SE
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
